US · Healthcare · Healthcare Plans
EPS came in at 2.51 against a street estimate of 0.89 — a beat of 182.0%.
Analysts rate Centene Corp a buy (10 buy, 9 hold, 0 sell out of 19) with an average price target of $70.67.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.06% |
| AQR Capital Management LLC | 6.80% |
| Vanguard Capital Management, LLC | 6.32% |
| State Street Corp | 4.38% |
| Vanguard Portfolio Management, LLC | 4.38% |
| Harris Associates L.P. | 2.85% |
| Geode Capital Management, LLC | 2.63% |
| Amvescap Plc. | 2.15% |
| Document | Date |
|---|---|
| Company announcement · Q3 2026 | 2026-07-29 |
| Results announced · Q3 2026 | 2026-07-28 |
| Quarterly report · Q2 2026 | 2026-07-28 |
| Board / officer change · Q2 2026 | 2026-06-22 |
| Board / officer change · Q2 2026 | 2026-05-15 |
| Quarterly report · Q1 2026 | 2026-04-28 |
| Proxy statement · Q2 2026 | 2026-03-26 |
| Annual report FY2025 | 2026-02-17 |
Readable in the app.
| Announcement | Date |
|---|---|
| Reaffirms 2026 full year GAAP and adjusted EPS guidance Centene Corporation announced that its senior management will meet with investors the week of February 23, 2026, to reaffirm previously provided 2026 guidance. The company maintains its full | 2026-02-23 |
| Fourth quarter and full year 2025 financial results with 2026 guidance presentation Centene Corporation filed an 8-K on February 6, 2026 to disclose its fourth quarter and full-year 2025 financial results, along with 2026 guidance. The actual financial details, earnings num | 2026-02-06 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Centene Corp — free to start.
Google PlayApp StoreData updated 2026-08-05.